Group 1 - Cardinal Health (CAH) stock received a Relative Strength (RS) Rating upgrade from 66 to 71, indicating an improvement in share price performance but still below the desired threshold of 80 [1] - Cencora has shown improved technical performance with a Relative Strength Rating upgrade, reaching a score of 86, although it remains shy of key thresholds [3] - Cencora reported $81.5 billion in sales last quarter, marking a significant performance in a challenging market environment [3] Group 2 - The market is currently influenced by tariff wars, which have led to sellers dominating the trading environment [3] - Cencora has been recognized as a new addition to the Big Cap 20, reflecting its rising prominence in the market [3] - The stock lists from Investor's Business Daily (IBD) include notable names such as Mueller Water and Netflix, indicating a diverse range of investment opportunities [3]
Cardinal Health Stock Scores Relative Strength Rating Upgrade